Next Article in Journal
Morphologies and Thermal Variability of Patterned Polymer Films with Poly(styrene-co-maleic anhydride)
Next Article in Special Issue
Preparation of Poly(acrylic acid) Hydrogel by Radiation Crosslinking and Its Application for Mucoadhesives
Previous Article in Journal
Molecular Modeling of PEGylated Peptides, Dendrimers, and Single-Walled Carbon Nanotubes for Biomedical Applications
Previous Article in Special Issue
Local Delivery of Antiproliferative Agents via Stents
Article Menu

Export Article

Open AccessReview
Polymers 2014, 6(3), 799-819;

Drugs and Polymers for Delivery Systems in OA Joints: Clinical Needs and Opportunities

Department of Orthopaedic Surgery, Maastricht University Medical Center, P. Debyelaan 25, 6229 HX Maastricht, the Netherlands
DSM Biomedical, Koestraat 1, 6167 RA Geleen, the Netherlands
Author to whom correspondence should be addressed.
Received: 31 January 2014 / Revised: 2 March 2014 / Accepted: 3 March 2014 / Published: 13 March 2014
(This article belongs to the Special Issue Polymers for Drug Delivery)
PDF [454 KB, uploaded 13 March 2014]


Osteoarthritis (OA) is a big burden of disease worldwide and one of the most common causes of disability in the adult population. Currently applied therapies consist of physical therapy, oral medication, intra-articular injections, and surgical interventions, with the main goal being to reduce pain and improve function and quality of life. Intra-articular (IA) administration of drugs has potential benefits in OA treatment because it minimizes systemic bioavailability and side effects associated with oral administration of drugs without compromising the therapeutic effect in the joint. However, IA drug residence time is short and there is a clinical need for a vehicle that is able to provide a sustained release long enough for IA therapy to fulfill its promise. This review summarizes the use of different polymeric systems and the incorporated drugs for IA drug delivery in the osteoarthritic joint with a primary focus on clinical needs and opportunities. View Full-Text
Keywords: osteoarthritis; drug delivery systems; DMOAD osteoarthritis; drug delivery systems; DMOAD

Figure 1

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Janssen, M.; Mihov, G.; Welting, T.; Thies, J.; Emans, P. Drugs and Polymers for Delivery Systems in OA Joints: Clinical Needs and Opportunities. Polymers 2014, 6, 799-819.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Polymers EISSN 2073-4360 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top